Novartis Content With CAR-T Manufacturing Ahead Of Crucial FDA Panel
Executive Summary
As crunch time approaches with its eagerly-anticipated CAR-T advisory meeting with FDA advisors on Wednesday, Novartis has been looking to allay fears about the manufacturing of CTL019.